Search
forResearch 10 of 328
- Hair Loss in Patients with Inflammatory Bowel Disease
- 266 Exploring the bidirectional impact of gastrointestinal and rosacea treatments on comorbid patients: A multi-center health records analysis
- Symptom management in inflammatory bowel disease
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Frequency and associated factors of hair loss among patients with inflammatory bowel disease
- Biotin Supplementation Ameliorates Murine Colitis by Preventing NF-κB Activation
- Immunosuppressive therapy in autoimmune disease — A review
- Ottawa, Ontario, Canada, February 13–16, 2013
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →